在饮食诱导的MASLD中,肝脏α-1b adrenoceptor的丧失加剧了炎症和星状细胞激活
Bernie Efole1,2, Sarra Beji1,2, Mathilde Mouchiroud2
1Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada.
概括
肝脏的α-1b adrenoceptor (ADRA1B) 抑制了与代谢功能障碍相关的脂肪性肝病 (MASLD) 的炎症. 肝细胞中ADRA1B信号的丧失使肝炎恶化,揭示了MASLD进展中的新型神经免疫途径.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经内分泌学神经内分泌学
- 免疫学 免疫学 免疫学
背景情况:
- 大脑通过神经内分泌和自主途径调节肝脏新陈代谢,这对于代谢功能障碍相关的脂肪性肝病 (MASLD) 发病至关重要.
- 在MASLD中注意到自主功能障碍,包括肝神经病变,但肝交感信号的具体作用仍然不清楚.
- 肝交感内置表明肝细胞上的上腺素受体可能会影响MASLD,其中上腺素受体α-1b (ADRA1B) 被确定为主导.
研究的目的:
- 研究肝细胞特异性上腺受体α-1b (ADRA1B) 在代谢功能障碍相关的脂肪性肝病 (MASLD) 的进展中的作用.
- 通过检查其对肝脏病理和代谢参数的影响,测试ADRA1B对MASLD进展起着保护作用的假设.
主要方法:
- 产生了肝细胞特异性的Adra1b淘汰赛小鼠 (Adra1b LKO).
- 使用Gubra Amylin NASH饮食诱导的MASLD长达32周.
- 通过自动图像分析 (MorphoQuant) 量化肝脏病理,并进行代谢表型化 (耐葡萄糖,胰岛素敏感性,胆酸组成).
主要成果:
- 肝细胞特异性Adra1b删除没有改变体重,肝脂积累,耐葡萄糖或胰岛素敏感性.
- 在Adra1bLKO小鼠中,肝炎炎症显著增加,其特征是TNF,IL-1β,MCP-1和IL-6表达率升高.
- 提升的TGF-β和α-平滑肌肉动因表明肝星细胞激活,同时增加了淘汰赛小鼠的循环胆红素水平.
结论:
- 在MASLD的背景下,肝脏ADRA1B在抑制炎症反应方面发挥着至关重要的,以前未知的作用.
- 肝细胞中ADRA1B信号的丧失加剧了肝炎,突出了MASLD进展中的关键神经免疫机制.
- 向肝脏ADRA1B可能通过调节炎症通路来提供一种新的治疗策略来管理MASLD.
相关概念视频
01:38Inflammation
61.6K
Overview
61.6K
01:24Chronic Pancreatitis I: Introduction
666
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
666
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:24Liver Regeneration
4.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.3K